Changes of liver xenobiotic-metabolizing function at different status of hepatic injury

Chinese Pharmacological Bulletin

Volumn 20, Issue 7, 2004, Pages 772-775

  Wang, Hui ^a   Chen, Man ^a   Liao, Zhang Xiu ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Antioxidative enzymes; Drug metabolizing enzymes; Hepatic fibrosis

Indexed keywords

CARBON TETRACHLORIDE; CATALASE; CYTOCHROME P450; CYTOCHROME P450 1A1; CYTOCHROME P450 2E1; CYTOCHROME P450 3A1; CYTOCHROME P450 3A2; DRUG METABOLIZING ENZYME; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; LIVER ENZYME;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL FRACTIONATION; CONTROLLED STUDY; ENZYME ACTIVITY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER INJURY; LIVER MICROSOME; NONHUMAN; RAT; XENOBIOTIC METABOLISM;

EID: 5044224264     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Bissell DM. Hepatic fibrosis as wound repair: A progress report [J]. J Gastroenterol, 1998, 33(2):295 -302.
2. Lown K, Kolars J, Turgeon K et al. The erythromycin breath test selectively measures P450 III A in patients with severe liver disease [J]. Clin Pharmacol Ther, 1992, 51(3):229 - 38.
3. Tanaka E. Clinical importance of non-genetic and genetic cytochrome P450 function tests in liver disease[J]. J Clin Pharm T-her, 1998, 23(3):161 -70.
4. Niemela O, Parkkila S. Halsted CH et al. Induction of cytochrome P450 enzymes and generation of protein -aldehyde adducts are associated with sex-dependent sensitivity to alcohol-induced liver disease in micropigs[J]. Hepatology, 1999,30(4):1011 -7.
5. Niemela O, Parkkila S, Juvonen RO et al. Cytochromes P450 2A6, 2El, and 3A and production of protein-aldehyde adducts in the liver of patients with alcoholic and non-alcoholic liver diseases [J]. J Hepatol, 2000,33 (6):893 - 901.
6. Peterson TC, Hodgson P, Femandez-Salguero P et al. Hepatic Hepatic fibrosis and cytochrome P450: Experimental models of fibrosis compared to AHR knockout mice[J]. Hepatol Res, 2000,17(2):112 -25.